4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-23-026519
General Counsel sold 682 shares at $9.88 ($6,736)
- General Counsel acquired 1,924 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ring Christine · General Counsel
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-30 | Exercise or conversion : show line 1 in the form | +1,924 | 10,722 | D | ||
| 2023-05-01 | Sale : show line 2 in the form | −682 | $9.88 | $6,736 | 10,040 | D |
| Open-market sales · 682 sh · avg $9.88 · $6,736 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-04-30 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −1,924 | 21,165 | D |
Loading xslF345X04/doc4.xml…